Using the term of progressive multiple sclerosis (PMS), we considered a combined population of persons with secondary progressive MS (SPMS) and primary progressive MS (PPMS)
Progressive multiple sclerosis (MS) will be a major area of research interest for years to come. No ...
In most cases, multiple sclerosis (MS) begins with a relapsing-remitting course followed by insidiou...
Approximately 85%-90 % of patients with multiple sclerosis (MS) will begin their disease with a cour...
Using the term of progressive multiple sclerosis (PMS), we considered a combined population of perso...
Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease of the central nervous s...
Multiple sclerosis (MS) is a chronic inflammatory condition of the central nervous system with heter...
Despite significant progress in the development of therapies for relapsing MS, progressive MS remain...
Since the earliest clinical descriptions of multiple sclerosis (MS), it has been recognised that a m...
Multiple sclerosis (MS) has long been recognised to have both a relopsing-remitting and progressive ...
Secondary progressive multiple sclerosis (SPMS) is characterized by progressive accumulation of disa...
Secondary progressive multiple sclerosis (SPMS) is diagnosed retrospectively and involves a clinical...
Background: It is unclear if all patients with relapsing remitting multiple sclerosis (RRMS) ultimat...
Primary progressive multiple sclerosis (PPMS) occurs in approximately 10%–15 % of the MS population ...
Multiple sclerosis (MS) has not been comprehensively characterized in the 21th century yet. MS is an...
Many challenges exist in the precise diagnosis and clinical management of secondary progressive mult...
Progressive multiple sclerosis (MS) will be a major area of research interest for years to come. No ...
In most cases, multiple sclerosis (MS) begins with a relapsing-remitting course followed by insidiou...
Approximately 85%-90 % of patients with multiple sclerosis (MS) will begin their disease with a cour...
Using the term of progressive multiple sclerosis (PMS), we considered a combined population of perso...
Multiple sclerosis (MS) is an autoimmune inflammatory demyelinating disease of the central nervous s...
Multiple sclerosis (MS) is a chronic inflammatory condition of the central nervous system with heter...
Despite significant progress in the development of therapies for relapsing MS, progressive MS remain...
Since the earliest clinical descriptions of multiple sclerosis (MS), it has been recognised that a m...
Multiple sclerosis (MS) has long been recognised to have both a relopsing-remitting and progressive ...
Secondary progressive multiple sclerosis (SPMS) is characterized by progressive accumulation of disa...
Secondary progressive multiple sclerosis (SPMS) is diagnosed retrospectively and involves a clinical...
Background: It is unclear if all patients with relapsing remitting multiple sclerosis (RRMS) ultimat...
Primary progressive multiple sclerosis (PPMS) occurs in approximately 10%–15 % of the MS population ...
Multiple sclerosis (MS) has not been comprehensively characterized in the 21th century yet. MS is an...
Many challenges exist in the precise diagnosis and clinical management of secondary progressive mult...
Progressive multiple sclerosis (MS) will be a major area of research interest for years to come. No ...
In most cases, multiple sclerosis (MS) begins with a relapsing-remitting course followed by insidiou...
Approximately 85%-90 % of patients with multiple sclerosis (MS) will begin their disease with a cour...
DOI
Add to ORKG